Related Experiment Video
Updated: Jul 4, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Management of medication overuse headache
Domenico D'Amico1, Licia Grazzi1, Stewart J Tepper2
1UOC Neuroalgologia, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
Abstract:
Medication overuse headache (MOH) is a secondary headache characterized by frequent use of acute or symptomatic migraine medications at a sufficient frequency to transform patients from episodic to chronic migraine. MOH represents a significant medical problem, with a serious burden on patients' lives and on society as a whole. MOH patients often have additional comorbidities, and the clinical challenge of helping patients reduce acute medication use and revert to episodic headache can be marked. Treatment includes education and prevention; withdrawal programs; pharmacological prophylaxis; multidisciplinary therapies with behavioral and noninvasive neuromodulation options; and scheduled, frequent follow-up to prevent relapses. The advent of anti-CGRP therapy monoclonal antibodies may provide an alternative to more extensive programs for less complex patients. This review also provides guidance for which patients may benefit most from coordinated integrated programs.
Insights
Medication overuse headache (MOH) is a chronic condition caused by frequent use of acute migraine medications. Treatment involves withdrawal, prevention, and multidisciplinary approaches, with new therapies offering alternatives.
Area of Science:
- Neurology
- Headache Medicine
Background:
- Medication overuse headache (MOH) transforms episodic migraines into chronic daily headaches.
- MOH poses a significant burden on patients and society due to its prevalence and complexity.
- Patients with MOH often present with comorbidities, complicating treatment strategies.
Approach:
- Review of current treatment strategies for MOH.
- Evaluation of educational, withdrawal, and prophylactic interventions.
- Assessment of multidisciplinary therapies including behavioral and neuromodulation options.
Key Points:
- Treatment requires patient education, medication withdrawal, and preventative strategies.
- Multidisciplinary approaches are crucial for managing complex MOH cases.
- Anti-CGRP monoclonal antibodies present a novel therapeutic option for select patients.
Conclusions:
- Integrated care programs are essential for effective MOH management.
- Guidance is provided for selecting patients who will benefit from coordinated programs.
- Future research should focus on optimizing treatment pathways for MOH.
Related Concept Videos
Management of Insomnia
Analgesia and Pain Management
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
Drug Therapy
Antianxiety Medications
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...

